U.S. Food and Drug Administration
Skip navigation FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
horizontal rule

Law Strengthens FDA

Topics on this Page

Introduction

President Bush signing the Food and Drug Administration Amendments Act (FDAAA) of 2007On September 27, President George W. Bush signed into law H.R. 3580, the Food and Drug Administration Amendments Act of 2007, with (from left to right) HHS Secretary Michael Leavitt, FDA Commissioner Andrew von Eschenbach, and Rep. Joe Barton of Texas in the Oval Office.  This new law represents a very significant addition to FDA authority.  Among the many components of the law, the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee and Modernization Act (MDUFMA) have been reauthorized and expanded. These programs will ensure that FDA staff have the additional resources needed to conduct the complex and comprehensive reviews necessary to new drugs and devices.

Two other important laws were reauthorized:  the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA). Both of these are designed to encourage more research into, and more development of, treatments for children.

Overall, this new law will provide significant benefits for those who develop medical products, and for those who use them.

What is FDA Doing?

News Updates

Law

Related Links

rule
PDF documents may be read with a free copy of the Adobe Acrobat Reader. Excel documents can be read with a free copy of Microsoft's Excel viewer .

rule

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Website Management Staff

link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page